Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and ...
Please provide your email address to receive an email when new articles are posted on . Pacemakers or implanted cardiac defibrillators that were retrieved postmortem, resterilized and reused in ...
Wearable electronic devices such as smart watches, worn by consumers to monitor their health, could interfere with the correct working of cardiac implantable electronic devices (CIEDs), posing serious ...
New System Builds On Sprint Quattro® Lead, Adding to the Company’s Portfolio of Innovative Technologies Proven to Treat Heart Rhythm Disorders MINNEAPOLIS – Medtronic, Inc. today announced the U.S.
In today’s world we have come to rely on our devices, such as smartphones, tablets and laptops, as a key element in all aspects of our lives. Whether it’s letting loved ones know we’re on our way, ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Please provide your email address to receive an email when new articles are posted on . A car park clinic for cardiac devices follow-up was associated with shorter visits and high patient satisfaction ...
DUBLIN--(BUSINESS WIRE)--The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report ...
Remote monitoring of patients with implantable cardiac devices reduced the mortality rate for cardiac patients by 50 percent and improved their clinical status by nearly 10 percent in a randomized ...
Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...
The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results